Suven Life Sciences Limited (SUVEN.NS) NSE
209.35
-7.98(-3.67%)
Currency In INR
- General
- Statistics
- Historical Data
- Profile
- Financials
209.35
-7.98(-3.67%)
Currency In INR
| Market Cap | 26.67B |
| Enterprise Value | 26.29B |
| P/E Ratio | -17.07 |
| PEG Ratio | 0.34 |
| Price/Sales Ratio | 664.1 |
| Price/Book Ratio | 16.67 |
| Enterprise/Revenue | 662.74 |
| Enterprise/EBITDA | -17.38 |
| Fiscal Year | March 31, 2025 |
| Most Recent Quarter | September 30, 2025 |
| Profit Margin | -38.9 |
| Operating Margin | -40.09 |
| Return On Assets | -0.81 |
| Return On Equity | -1.58 |
| Revenue | 66.56M |
| Revenue/Share | 0.32 |
| Gross Profit | -276.33M |
| EBITDA | -1.55B |
| Net Income | -1.61B |
| Diluted EPS | -7.36 |
| Total Cash | 2.59B |
| Total Cash/Share | 11.54 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 5.11 |
| Book Value Per Share | 12.56 |
| 52-Week Change | 70.63 |
| 52-Week High | 299.99 |
| 52-Week Low | 123 |
| Moving Average 50 Days | 161.92 |
| Moving Average 200 Days | 185.42 |
| Average Volume | 514,626 |
| Shares Outstanding | 224.01M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 217:200 |
| Last Split Date | October 17, 2022 |